Our goals for this project include (1) Design competency framework and learning objectives that define the role and scope of practice for a BHSS; (2) Scale the role for Washington state by creating processes for integrating the BHSS Clinical Training Program into existing four-year degree programs in the behavioral healthcare field; (3) Partner with Washington state higher education institutions to adopt the BHSS Clinical Training Program; (4) Develop curricular resources to share with Washington State colleges and universities including an Educator’s Guide; (5) Collaborate with government agencies, employers, and policy groups to implement legislation establishing a BHSS credential in Washington state.
For information, please contact:
Bill O’Connell, Ed.D.
Director, Clinical Training Program
Savannah Tidwell, BS
tidwell1@uw.edu
Program Manager, Clinical Training Program
This project developed and delivered training and technical assistance in Motivational Interviewing for primary care professionals in OR state.
Perinatal depression affects 10-20% of pregnant and postpartum individuals, impairing parenting self-efficacy and mother-infant interactions and contributing to negative maternal-child outcomes. This research will test comprehensive perinatal depression treatment, Maternal Infant and Dyadic Care (MInD), which includes a brief version of the Promoting First Relationships parenting intervention implemented within perinatal collaborative care, against perinatal collaborative care (CC) only. The aims of this study are to (1) compare the effects of MInD vs. usual perinatal CC on depression, (2) explore associations between parenting self-efficacy, dyadic interaction, and depression to inform a mediational hypothesis, and (3) examine and compare care utilization, trial feasibility, and perceived match of treatment to patient need.
Standardized measurements of unhealthy drinking and alcohol use disorder symptoms are integral to addressing alcohol problems. However, surprisingly little is known about how measures of alcohol consumption and alcohol use disorder symptoms function when they are used in real-world routine care settings and documented in electronic health records (EHRs).
We propose to leverage EHRs to understand how measures of alcohol consumption and DSM-5 alcohol use disorder symptoms function in the context of real-world routine care, including by understanding how these measures function psychometrically overall and across demographic groups (age, sex, race, and ethnicity) and how they are associated with subsequent health outcomes obtained from EHRs.
Deaths related to the opioid overdose epidemic remain at an all-time high
across the country despite significant efforts to reduce them. There is a
pressing need to support medication treatment for opioid use disorder (OUD) to
help people stay in treatment and reduce the risk of overdose death and other
serious health consequences of untreated addiction. Smartphone-based apps can
facilitate the delivery of an evidence-based approach called contingency
management that incentivizes use of medications for OUD, reduces use of
non-prescribed opioids and improves retention in OUD treatment.
This study will leverage a commercially available smartphone app that can
bring this much-needed behavioral support to patients receiving OUD treatment
in a primary care clinic and in a specialty OUD treatment clinic. The approach
offers a potentially non-labor intensive, cost-effective and highly scalable
means of delivering OUD care.
This project will create a mentored research training program for University of Washington medical students to engage in substance use disorder-focused research and clinical practice during their medical school training.
This project will develop a telephonic collaborative care model for opioid use disorder and depression and then conduct a pragmatic trial to test the model of care management primary care clinics in Washington state and Indiana.
This multi-site study will test the efficacy of an intervention to train and equip pharmacists to provide naloxone, an overdose antidote, to patients using prescribed and illicit opioids, to improve opioid safety and prevent opioid-involved adverse events. The study will carry out a stepped-wedge, cluster randomized trial implemented over five waves, within two chain community pharmacies across four states with varying pharmacy-based naloxone distribution laws: Oregon, Washington, Massachusetts and New Hampshire.
Our specific study aims are to: 1) integrate two successful demonstration research projects into one cohesive educational program (MOON+), 2) evaluate the effectiveness of MOON + on naloxone-related outcomes, and 3) use mixed methods to further explore the impact and implementation of MOON+ and associated factors (e.g., state policy, store policy, region).
This research will test the psychometric performance of a patient-report questionnaire that assesses DSM-5 substance use disorder symptoms as part of routine primary care.